This suggests that YAP-ALOXE3 signaling may be a potential biomarker for predicting cancer cell responsiveness to ferroptosis induction, particularly in hepatocellular carcinoma (HCC) [24]. This evidence concerns the gene YAP1 and hepatocellular carcinoma.